Off-target assessment for therapeutic gene editing targeting BCL11A enhancer
We performed gene editing on BCL11A enchancer with four therapeutic guides: sgRNA 1617 + sgRNA 1450 and sgRNA 1618 + sgRNA 1449. Here, we uploaded the off-target assessments of our proposed therapy.